LV10083A - Panemiens (6S)- un (6R)-tetrahidrofolijskabes iegusanai - Google Patents
Panemiens (6S)- un (6R)-tetrahidrofolijskabes iegusanaiInfo
- Publication number
- LV10083A LV10083A LV930220A LV930220A LV10083A LV 10083 A LV10083 A LV 10083A LV 930220 A LV930220 A LV 930220A LV 930220 A LV930220 A LV 930220A LV 10083 A LV10083 A LV 10083A
- Authority
- LV
- Latvia
- Prior art keywords
- acid
- tetrahydrofolic
- addition salts
- sulphonic
- sulphuric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Steroid Compounds (AREA)
- Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
- Liquid Crystal Substances (AREA)
- Oscillators With Electromechanical Resonators (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH108/91A CH681303A5 (lv) | 1991-01-16 | 1991-01-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10083A true LV10083A (lv) | 1994-05-10 |
LV10083B LV10083B (en) | 1995-04-20 |
Family
ID=4179454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-93-220A LV10083B (en) | 1991-01-16 | 1993-04-02 | Method of preparation of (6s)- and (6r)-tetrahydrofolic acid |
Country Status (25)
Country | Link |
---|---|
US (1) | US5324836A (lv) |
EP (1) | EP0495204B1 (lv) |
JP (1) | JPH0739417B2 (lv) |
KR (1) | KR100207133B1 (lv) |
CN (1) | CN1030079C (lv) |
AT (1) | ATE123777T1 (lv) |
AU (1) | AU654993B2 (lv) |
CA (1) | CA2059103C (lv) |
CH (1) | CH681303A5 (lv) |
DE (1) | DE59105722D1 (lv) |
DK (1) | DK0495204T3 (lv) |
ES (1) | ES2075315T3 (lv) |
FI (1) | FI109906B (lv) |
GE (1) | GEP19971019B (lv) |
HU (1) | HU207083B (lv) |
IE (1) | IE72164B1 (lv) |
IL (1) | IL100478A (lv) |
LV (1) | LV10083B (lv) |
MX (1) | MX9200063A (lv) |
NO (1) | NO301422B1 (lv) |
NZ (1) | NZ241245A (lv) |
PT (1) | PT100014B (lv) |
RU (1) | RU2099340C1 (lv) |
TW (1) | TW198033B (lv) |
ZA (1) | ZA92291B (lv) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH682664A5 (en) * | 1991-10-15 | 1993-10-29 | Eprova Ag | Stable salts of 5,10-methylene tetrahydrofolate. |
DE4136921A1 (de) * | 1991-11-11 | 1993-05-13 | Knoll Ag | Verfahren zur trennung von 5-methyl-tetrahydrofolsaeure |
CH683262A5 (it) * | 1992-01-22 | 1994-02-15 | Applied Pharma Res | Procedimento per la separazione dei diastereomeri del sale di calcio dell'acido (6(R,S)-N-formiltetraidrofolico). |
IT1254635B (it) * | 1992-02-20 | 1995-09-28 | Bracco Spa | Processo per la separazione degli stereoisomeri dell'acido folinico |
CH684644A5 (de) * | 1992-07-13 | 1994-11-15 | Eprova Ag | 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen. |
CH686672A5 (de) * | 1992-12-01 | 1996-05-31 | Cerbios Pharma Sa | Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure. |
CH686369A5 (de) * | 1994-05-09 | 1996-03-15 | Eprova Ag | Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure. |
CH689831A5 (de) * | 1995-11-07 | 1999-12-15 | Eprova Ag | Stabile kristalline Tetrahydrofolsaeure-Salze. |
CH693905A5 (de) * | 1999-04-15 | 2004-04-15 | Eprova Ag | Stabile kristalline Salze von 5-Methyltetrahydrofolsäure. |
CH695217A5 (de) * | 1999-07-14 | 2006-01-31 | Merck Eprova Ag | Verfahren zur Trennung optischer Isomeren von Tetrahydrofolsäureestersalzen und Tetrahydrofolsäure. |
CH694251A5 (de) * | 1999-07-14 | 2004-10-15 | Eprova Ag | Herstellung von Tetrahydropterin und Derivaten. |
AU2002241918B2 (en) | 2001-01-16 | 2007-01-18 | Gr Intellectual Reserve, Llc | Enhanced data storage and retrieval devices and systems and methods for utilizing the same |
ITMI20020132A1 (it) | 2002-01-25 | 2003-07-25 | Gmt Fine Chemicals Sa | Processo per l'ottenimento dell'acido (6s)-5,6,7,8-tetraidrofolico |
WO2004057579A2 (en) | 2002-11-21 | 2004-07-08 | Berkshire Laboratories, Inc. | Enhanced data storage and retrieval devices and systems and methods for utilizing same |
CH696717A5 (de) * | 2004-02-20 | 2007-10-31 | Cerbios Pharma Sa | Konzentrierte, stabile Losung, insbesondere eine Injektionslosung oder Infusionslosung, welche nebst Wasser entweder (6S)-Natrium-Folinat oder (6S)-Kalium-Folinat entholt |
CH698729B1 (de) | 2007-05-30 | 2009-10-15 | Cerbios Pharma Sa | Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure. |
CN101407518A (zh) * | 2007-10-11 | 2009-04-15 | 南京莱尔生物化工有限公司 | (6r,s)-5-甲酰-四氢叶酸的拆分及其成盐的方法 |
CN104334561B (zh) | 2012-04-13 | 2016-06-22 | 连云港金康和信药业有限公司 | 化合物jk12a及其制备 |
CN104045640B (zh) * | 2013-03-14 | 2016-04-06 | 天津康鸿医药科技发展有限公司 | 一种制备高纯度左亚叶酸钙的方法 |
CN104774169B (zh) * | 2014-01-15 | 2017-02-15 | 上海韶远试剂有限公司 | 一种利用非手性助剂进行非对映异构体拆分的新方法 |
CN108164531B (zh) * | 2018-02-12 | 2019-11-05 | 江苏红豆杉药业有限公司 | 一种l-5-甲基四氢叶酸钙的制备方法 |
AU2019297309B2 (en) | 2018-07-06 | 2024-08-29 | Merck Patent Gmbh | Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3468886A (en) * | 1967-10-23 | 1969-09-23 | Us Health Education & Welfare | Tetrahydrohomofolic acid sulfate and synthesis thereof |
DE2063027A1 (de) * | 1969-12-26 | 1971-07-01 | Yamanouchi Pharmaceutical Co Ltd , Tokio | Salz einer basischen Aminosäure der 5 6,7,8 Tetrahydrofolsaure |
JPS4832120A (lv) * | 1971-08-31 | 1973-04-27 | ||
US4665176A (en) * | 1984-10-23 | 1987-05-12 | Mitsui Toatsu Chemicals, Incorporated | Process for the preparation of 5,6,7,8-tetrahydrofolic acid |
GB8621268D0 (en) * | 1986-09-03 | 1986-10-08 | Univ Strathclyde | Separation of substances |
CH673459A5 (lv) * | 1987-05-15 | 1990-03-15 | Eprova Ag | |
DE3821875C1 (lv) * | 1988-06-29 | 1990-02-15 | Eprova Ag, Forschungsinstitut, Schaffhausen, Ch | |
JPH0265787A (ja) * | 1988-08-30 | 1990-03-06 | Kyowa Hakko Kogyo Co Ltd | L(‐)‐テトラヒドロ葉酸の製造法 |
CH676981A5 (lv) * | 1988-11-11 | 1991-03-28 | Eprova Ag | |
FR2643081B1 (fr) * | 1989-02-14 | 1991-06-07 | Panmedica Sa | Folates de magnesium, procede de preparation et compositions pharmaceutiques |
US5173488A (en) * | 1989-08-21 | 1992-12-22 | American Cyanamid Company | Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
DK0432441T3 (da) * | 1989-12-11 | 1996-07-29 | American Cyanamid Co | Fremgangsmåde til fremstilling af optisk rene diastereoisomere af tetrahydrofolatforbindelser |
CH680731A5 (lv) * | 1990-04-12 | 1992-10-30 | Sapec Fine Chemicals |
-
1991
- 1991-01-16 CH CH108/91A patent/CH681303A5/de not_active IP Right Cessation
- 1991-11-27 TW TW080109353A patent/TW198033B/zh active
- 1991-12-06 RU SU915010253A patent/RU2099340C1/ru not_active IP Right Cessation
- 1991-12-12 DK DK91121326.2T patent/DK0495204T3/da not_active Application Discontinuation
- 1991-12-12 EP EP91121326A patent/EP0495204B1/de not_active Expired - Lifetime
- 1991-12-12 DE DE59105722T patent/DE59105722D1/de not_active Expired - Lifetime
- 1991-12-12 ES ES91121326T patent/ES2075315T3/es not_active Expired - Lifetime
- 1991-12-12 AT AT91121326T patent/ATE123777T1/de not_active IP Right Cessation
- 1991-12-23 IL IL10047891A patent/IL100478A/en not_active IP Right Cessation
-
1992
- 1992-01-08 NZ NZ241245A patent/NZ241245A/en not_active IP Right Cessation
- 1992-01-08 MX MX9200063A patent/MX9200063A/es unknown
- 1992-01-09 CA CA002059103A patent/CA2059103C/en not_active Expired - Lifetime
- 1992-01-10 KR KR1019920000260A patent/KR100207133B1/ko not_active IP Right Cessation
- 1992-01-14 JP JP4005095A patent/JPH0739417B2/ja not_active Expired - Lifetime
- 1992-01-15 AU AU10254/92A patent/AU654993B2/en not_active Ceased
- 1992-01-15 CN CN92100247A patent/CN1030079C/zh not_active Expired - Lifetime
- 1992-01-15 HU HU9200134A patent/HU207083B/hu not_active IP Right Cessation
- 1992-01-15 FI FI920180A patent/FI109906B/fi active
- 1992-01-15 ZA ZA92291A patent/ZA92291B/xx unknown
- 1992-01-15 IE IE920112A patent/IE72164B1/en not_active IP Right Cessation
- 1992-01-15 NO NO920197A patent/NO301422B1/no not_active IP Right Cessation
- 1992-01-15 PT PT100014A patent/PT100014B/pt not_active IP Right Cessation
-
1993
- 1993-04-02 LV LVP-93-220A patent/LV10083B/lv unknown
- 1993-04-08 US US08/044,886 patent/US5324836A/en not_active Expired - Lifetime
- 1993-07-14 GE GEAP19931024A patent/GEP19971019B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV10083A (lv) | Panemiens (6S)- un (6R)-tetrahidrofolijskabes iegusanai | |
TW229156B (lv) | ||
ES2040261T3 (es) | Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos. | |
HUT45984A (en) | Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts | |
HUT53364A (en) | Process for producing new 2-aminopyrimidinone derivatives and pharmaceutical compositions comprising same as active ingredient | |
DE3873578D1 (de) | Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
DE3485419D1 (de) | Glyzerinderivate. | |
ATE142627T1 (de) | Methode zur verbesserung des schlafes | |
JPS6442472A (en) | Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient | |
FI864970A (fi) | Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning. | |
HUT51597A (en) | Process for production of derivatives of n,n-disubstituated diaryl-alcane-carbonic acid amid and medical compositions containing them as active substances | |
GR3006606T3 (lv) | ||
ES2066052T3 (es) | Esteres del acido cinamico. | |
ATE42087T1 (de) | Verfahren zur herstellung von dichtem wasserfreiem natriumcarbonat und nach diesem verfahren hergestelltes dichtes wasserfreies natriumcarbonat. | |
FR2678931B1 (fr) | Nouveau derive de l'amino-2 naphtyridine, sa preparation et son emploi. | |
HUT47900A (en) | Process for producing new amides of butenic acid and pharmaceutical compositions containing them as active components | |
HUT45062A (en) | Process for producing 1-hydroxy-5-oxo-5h-pindo/3,2-a/ phenoxazine-3-carboxylic acid esters and pharmaceuticals comprising the same as active ingredient | |
ZA885358B (en) | Uricosuric composition | |
JPS646266A (en) | Optically active alcohol and its production |